Global Asthma Preventive Market Research Report 2024

Publication ID:

PB502247523

Publication Date:

March 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Asthma prophylaxis must be taken over a period of time to be effective. These drugs, however, are not suitable for the onset of the disease.

The global Asthma Preventive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Asthma Preventive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Preventive.

Report Scope

The Asthma Preventive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Preventive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Asthma Preventive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Pfizer

Abbot

Novartis

Roche

GSK

Merck

Astrazeneca

Biotest AG

Boehringer Ingelheim

Chiesi

Sumitomo Dainippon Pharma

Amgen

Segment by Type

Sodium Cromolyn

Prednisolone

Segment by Application

Children

Adult

Consumption by Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Asthma Preventive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Asthma Preventive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Asthma Preventive Market Overview

1.1 Product Overview and Scope of Asthma Preventive

1.2 Asthma Preventive Segment by Type

1.2.1 Global Asthma Preventive Market Value Comparison by Type (2024-2030)

1.2.2 Sodium Cromolyn

1.2.3 Prednisolone

1.3 Asthma Preventive Segment by Application

1.3.1 Global Asthma Preventive Market Value by Application: (2024-2030)

1.3.2 Children

1.3.3 Adult

1.4 Global Asthma Preventive Market Size Estimates and Forecasts

1.4.1 Global Asthma Preventive Revenue 2019-2030

1.4.2 Global Asthma Preventive Sales 2019-2030

1.4.3 Global Asthma Preventive Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Asthma Preventive Market Competition by Manufacturers

2.1 Global Asthma Preventive Sales Market Share by Manufacturers (2019-2024)

2.2 Global Asthma Preventive Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Asthma Preventive Average Price by Manufacturers (2019-2024)

2.4 Global Asthma Preventive Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Asthma Preventive, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Asthma Preventive, Product Type & Application

2.7 Asthma Preventive Market Competitive Situation and Trends

2.7.1 Asthma Preventive Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Asthma Preventive Players Market Share by Revenue

2.7.3 Global Asthma Preventive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Asthma Preventive Retrospective Market Scenario by Region

3.1 Global Asthma Preventive Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Asthma Preventive Global Asthma Preventive Sales by Region: 2019-2030

3.2.1 Global Asthma Preventive Sales by Region: 2019-2024

3.2.2 Global Asthma Preventive Sales by Region: 2025-2030

3.3 Global Asthma Preventive Global Asthma Preventive Revenue by Region: 2019-2030

3.3.1 Global Asthma Preventive Revenue by Region: 2019-2024

3.3.2 Global Asthma Preventive Revenue by Region: 2025-2030

3.4 North America Asthma Preventive Market Facts & Figures by Country

3.4.1 North America Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Asthma Preventive Sales by Country (2019-2030)

3.4.3 North America Asthma Preventive Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Asthma Preventive Market Facts & Figures by Country

3.5.1 Europe Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Asthma Preventive Sales by Country (2019-2030)

3.5.3 Europe Asthma Preventive Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Asthma Preventive Market Facts & Figures by Country

3.6.1 Asia Pacific Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Asthma Preventive Sales by Country (2019-2030)

3.6.3 Asia Pacific Asthma Preventive Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Asthma Preventive Market Facts & Figures by Country

3.7.1 Latin America Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Asthma Preventive Sales by Country (2019-2030)

3.7.3 Latin America Asthma Preventive Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Asthma Preventive Market Facts & Figures by Country

3.8.1 Middle East and Africa Asthma Preventive Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Asthma Preventive Sales by Country (2019-2030)

3.8.3 Middle East and Africa Asthma Preventive Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Asthma Preventive Sales by Type (2019-2030)

4.1.1 Global Asthma Preventive Sales by Type (2019-2024)

4.1.2 Global Asthma Preventive Sales by Type (2025-2030)

4.1.3 Global Asthma Preventive Sales Market Share by Type (2019-2030)

4.2 Global Asthma Preventive Revenue by Type (2019-2030)

4.2.1 Global Asthma Preventive Revenue by Type (2019-2024)

4.2.2 Global Asthma Preventive Revenue by Type (2025-2030)

4.2.3 Global Asthma Preventive Revenue Market Share by Type (2019-2030)

4.3 Global Asthma Preventive Price by Type (2019-2030)

5 Segment by Application

5.1 Global Asthma Preventive Sales by Application (2019-2030)

5.1.1 Global Asthma Preventive Sales by Application (2019-2024)

5.1.2 Global Asthma Preventive Sales by Application (2025-2030)

5.1.3 Global Asthma Preventive Sales Market Share by Application (2019-2030)

5.2 Global Asthma Preventive Revenue by Application (2019-2030)

5.2.1 Global Asthma Preventive Revenue by Application (2019-2024)

5.2.2 Global Asthma Preventive Revenue by Application (2025-2030)

5.2.3 Global Asthma Preventive Revenue Market Share by Application (2019-2030)

5.3 Global Asthma Preventive Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Asthma Preventive Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Abbot

6.2.1 Abbot Corporation Information

6.2.2 Abbot Description and Business Overview

6.2.3 Abbot Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Abbot Asthma Preventive Product Portfolio

6.2.5 Abbot Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Corporation Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis Asthma Preventive Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Roche

6.4.1 Roche Corporation Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Roche Asthma Preventive Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 GSK

6.5.1 GSK Corporation Information

6.5.2 GSK Description and Business Overview

6.5.3 GSK Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GSK Asthma Preventive Product Portfolio

6.5.5 GSK Recent Developments/Updates

6.6 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Merck Asthma Preventive Product Portfolio

6.6.5 Merck Recent Developments/Updates

6.7 Astrazeneca

6.6.1 Astrazeneca Corporation Information

6.6.2 Astrazeneca Description and Business Overview

6.6.3 Astrazeneca Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Astrazeneca Asthma Preventive Product Portfolio

6.7.5 Astrazeneca Recent Developments/Updates

6.8 Biotest AG

6.8.1 Biotest AG Corporation Information

6.8.2 Biotest AG Description and Business Overview

6.8.3 Biotest AG Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Biotest AG Asthma Preventive Product Portfolio

6.8.5 Biotest AG Recent Developments/Updates

6.9 Boehringer Ingelheim

6.9.1 Boehringer Ingelheim Corporation Information

6.9.2 Boehringer Ingelheim Description and Business Overview

6.9.3 Boehringer Ingelheim Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Boehringer Ingelheim Asthma Preventive Product Portfolio

6.9.5 Boehringer Ingelheim Recent Developments/Updates

6.10 Chiesi

6.10.1 Chiesi Corporation Information

6.10.2 Chiesi Description and Business Overview

6.10.3 Chiesi Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Chiesi Asthma Preventive Product Portfolio

6.10.5 Chiesi Recent Developments/Updates

6.11 Sumitomo Dainippon Pharma

6.11.1 Sumitomo Dainippon Pharma Corporation Information

6.11.2 Sumitomo Dainippon Pharma Asthma Preventive Description and Business Overview

6.11.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio

6.11.5 Sumitomo Dainippon Pharma Recent Developments/Updates

6.12 Amgen

6.12.1 Amgen Corporation Information

6.12.2 Amgen Asthma Preventive Description and Business Overview

6.12.3 Amgen Asthma Preventive Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Amgen Asthma Preventive Product Portfolio

6.12.5 Amgen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Asthma Preventive Industry Chain Analysis

7.2 Asthma Preventive Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Asthma Preventive Production Mode & Process

7.4 Asthma Preventive Sales and Marketing

7.4.1 Asthma Preventive Sales Channels

7.4.2 Asthma Preventive Distributors

7.5 Asthma Preventive Customers

8 Asthma Preventive Market Dynamics

8.1 Asthma Preventive Industry Trends

8.2 Asthma Preventive Market Drivers

8.3 Asthma Preventive Market Challenges

8.4 Asthma Preventive Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

Companies Mentioned:

Pfizer

Abbot

Novartis

Roche

GSK

Merck

Astrazeneca

Biotest AG

Boehringer Ingelheim

Chiesi

Sumitomo Dainippon Pharma

Amgen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂